127 related articles for article (PubMed ID: 14667761)
1. Combine EUROPA and HOPE.
Fuller JA
Lancet; 2003 Dec; 362(9399):1937. PubMed ID: 14667761
[No Abstract] [Full Text] [Related]
2. The EUROPA trial.
Boos C
Lancet; 2003 Dec; 362(9399):1935; author reply 1936-7. PubMed ID: 14667756
[No Abstract] [Full Text] [Related]
3. Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
White HD
Lancet; 2003 Sep; 362(9386):755-7. PubMed ID: 13678865
[No Abstract] [Full Text] [Related]
4. The EUROPA trial.
Stoschitzky K
Lancet; 2003 Dec; 362(9399):1935-6; author reply 1936-7. PubMed ID: 14667757
[No Abstract] [Full Text] [Related]
5. The EUROPA trial.
Kwaku M; Burman KD; Becker KL; Mannan M
Lancet; 2003 Dec; 362(9399):1935; author reply 1936-7. PubMed ID: 14667758
[No Abstract] [Full Text] [Related]
6. EUROPA: clinical benefits, clinical promise.
Cardiovasc J S Afr; 2004; 15(3):147. PubMed ID: 15356915
[No Abstract] [Full Text] [Related]
7. Blocking the renin-angiotensin-aldosterone system or lowering the blood pressure: does EUROPA help?
Mackay JA
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):205-6. PubMed ID: 14689366
[TBL] [Abstract][Full Text] [Related]
8. [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].
Perepech NB
Kardiologiia; 2004; 44(3):106-10. PubMed ID: 15489840
[No Abstract] [Full Text] [Related]
9. ["Using chance, despite high NNT"].
Zeiher A
MMW Fortschr Med; 2003 Sep; 145(38):12. PubMed ID: 14603674
[No Abstract] [Full Text] [Related]
10. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
Boos CJ
Med Sci Monit; 2004 Dec; 10(12):SR23-8. PubMed ID: 15567997
[TBL] [Abstract][Full Text] [Related]
11. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
Dinicolantonio JJ; Lavie CJ; O'Keefe JH
Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903
[TBL] [Abstract][Full Text] [Related]
12. The EUROPA trial.
Brophy JM
Lancet; 2003 Dec; 362(9399):1936; author reply 1936-7. PubMed ID: 14667759
[No Abstract] [Full Text] [Related]
13. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
[TBL] [Abstract][Full Text] [Related]
14. [ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study].
Böhm M
Internist (Berl); 2004 Oct; 45(10):1196-8. PubMed ID: 15372169
[No Abstract] [Full Text] [Related]
15. The ADVANCE trial.
Procopiou M
Lancet; 2008 Jan; 371(9606):25; author reply 26. PubMed ID: 18177767
[No Abstract] [Full Text] [Related]
16. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
17. Do ACE inhibitors have a real role in coronary artery disease?
Cardiovasc J S Afr; 2003; 14(3):156. PubMed ID: 12934579
[No Abstract] [Full Text] [Related]
18. PERSUADE...(a EUROPA sub-study)...results: perindopril protects diabetic patients with coronary disease from cardiovascular death and heart attacks.
Cardiovasc J S Afr; 2004; 15(3):146. PubMed ID: 15356914
[No Abstract] [Full Text] [Related]
19. Do all patients with coronary artery disease benefit from angiotensin converting enzyme inhibitors?
Shah AD; Arora RR
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):281-3. PubMed ID: 16382264
[TBL] [Abstract][Full Text] [Related]
20. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
Haghfelt T; Haghfelt A
Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
